Insider at issuer (NYSE: AXP) files to sell $8.3M in stock
Rhea-AI Filing Summary
An insider of the issuer with symbol AXP has filed a notice to sell 23,385 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $8,346,340.35. The filing notes that 688,851,653 shares of this class were outstanding.
The shares to be sold were recently acquired through option exercises and restricted stock vesting under registered plans. On 02/05/2026, 11,793 shares and 867 shares were obtained via option exercises paid in cash, and on 02/01/2026, 10,725 shares vested as restricted stock.
The person for whose account the shares will be sold represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 notice for a multi‑million dollar insider stock sale.
This Form 144 outlines a proposed sale of 23,385 common shares of the AXP issuer, with an aggregate market value of about $8,346,340.35. For a large-cap company with 688,851,653 shares outstanding, this represents a small fraction of the equity float.
The shares come from very recent option exercises and restricted stock vesting under registered plans on 02/01/2026 and 02/05/2026. That pattern is consistent with normal executive compensation events being monetized, rather than a long-held stake being liquidated.
The filer explicitly represents they are not aware of any material adverse information about the issuer that has not been publicly disclosed. The actual impact of this type of sale typically depends on overall trading volume and future disclosures in company filings, rather than on the notice itself.
FAQ
What does the AXP Form 144 filing disclose about the planned stock sale?
What trading representation does the AXP Form 144 filer make about material information?
When and where is the AXP Form 144 stock sale expected to occur?